Back

Long-term clinical outcomes of vasodilating beta-blockers in acute myocardial infarction patients with preserved left ventricular ejection fraction after a successful stent implantation

10 May 2026 (14:30 - 16:00)
Organised by: Logo
Congress Presentation Part of: ePosters in pharmacology and pharmacotherapy (1) Beta-Blockers HFA Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Mr Doyoon Lee

Jeju (Korea (Republic of))

5 More presentations in this session

Presentation thumbnail
Current clinical use of edoxaban 15 mg in hospitalized patients with heart failure: analysis from the JROAD-DPC database
Doctor Y. Fujimoto (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Anticoagulants and pulmonary embolism: the surprising impact of apixaban on bilateral embolism
Doctor R. Brandao (Amadora, PT)
Abstract Slides
Presentation thumbnail
Pulmonary Embolism in anticoagulated patients: a retrospective single-centered cohort comparing data from the PIOPED II study
Doctor R. Brandao (Amadora, PT)
Abstract Slides
Presentation thumbnail
Nonuse of oral anticoagulation and outcomes across the ejection-fraction spectrum in acute heart failure with atrial fibrillation
Doctor J. Yamamoto (Tokyo, JP)
Abstract Slides
Presentation thumbnail
Cardiac adverse event profiles of EGFR tyrosine kinase inhibitors: a disproportionality analysis using eudravigilance
Doctor Y. Shhab (Bucharest, RO)
Abstract Slides

Access the full session

Session thumbnail
ePosters in pharmacology and pharmacotherapy (1)

The Event

Event poster

Heart Failure 2026

10 May 2026 14:30 CET
You may be interested in
thumbnail
Webinar
Are beta-blockers still indicated after myocardial infarction?
thumbnail
Congress Presentation
Betablockers post-acute myocardial infarction
thumbnail
Congress Presentation
Discussant review - REBOOT-CNIC, BETAMI-DANBLOCK, CAPITAL-RCT

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources